Fermenta Biotech Regulatory Approval

Board Meeting Date

Fermenta Biotech Board Meeting Date

Fermenta Biotech schedules a board meeting on November 5, 2026 to approve unaudited quarterly and half-year results. The trading window stays closed until 48 hours after results.

Other Announcement

Fermenta Biotech Other Announcement

Fermenta Biotech Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.

Promoter Selling

Fermenta Biotech Promoter Selling

Fermenta Biotech Limited promoter Preeti Thakkar sold 11,65,938 equity shares (3.96%) in the open market. Her shareholding decreased from 7.61% to 3.65% following the transaction.

Promoter Selling

Fermenta Biotech Promoter Selling: ₹55.34 Cr

Fermenta Biotech Ltd promoter Preeti Thakkar sold 11,65,938 equity shares via open market sale. The transaction valued at ₹55.34 Crore reduced her stake from 7.61% to 3.65%.

Value

₹55.34 Cr

Other Announcement

Fermenta Biotech Other Announcement

KMP Sumesh Gandhi sold a total of 3,900 equity shares in three separate market transactions on September 7, 8, and 9, 2026.

Value

₹0.20 Cr

PartnershipAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Fermenta Biotech Partnership

Fermenta Biotech Limited signed an exclusive licence agreement with VIT Vellore to commercialize Vitamin B12 fortification technology for fermented foods, enhancing its product portfolio.

From

Vellore Institute of Technology (VIT), Vellore

Regulatory Approval360 One Wam Ltd 360ONEAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

360 One Wam Regulatory Approval

360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.

Regulatory ApprovalNesco Ltd NESCOAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Nesco Regulatory Approval

Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.

Regulatory ApprovalGrasim Industries Ltd GRASIMAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Grasim Industries Regulatory Approval

CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.

Regulatory ApprovalVedavaag Systems Ltd VEDAVAAG

Vedavaag Systems Regulatory Approval

Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.

Regulatory ApprovalHikal Ltd HIKALAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

Regulatory ApprovalSun Pharmaceutical Industries Ltd SUNPHARMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.